"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 4 | 1 | 5 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 4 | 7 |
| 2003 | 4 | 8 | 12 |
| 2004 | 6 | 4 | 10 |
| 2005 | 3 | 5 | 8 |
| 2006 | 15 | 2 | 17 |
| 2007 | 10 | 8 | 18 |
| 2008 | 10 | 8 | 18 |
| 2009 | 11 | 3 | 14 |
| 2010 | 17 | 6 | 23 |
| 2011 | 16 | 10 | 26 |
| 2012 | 19 | 17 | 36 |
| 2013 | 9 | 10 | 19 |
| 2014 | 17 | 15 | 32 |
| 2015 | 18 | 7 | 25 |
| 2016 | 43 | 30 | 73 |
| 2017 | 720 | 471 | 1191 |
| 2018 | 793 | 479 | 1272 |
| 2019 | 360 | 230 | 590 |
| 2020 | 54 | 115 | 169 |
| 2021 | 36 | 72 | 108 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans. Am J Epidemiol. 2021 11 02; 190(11):2405-2419.
-
Phlyctenular Keratoconjunctivitis in a Patient With COVID-19 Infection. Cornea. 2021 Nov 01; 40(11):1502-1504.
-
Impact of COVID-19 Pandemic on Infectious Keratitis Outcomes: A Retrospective Multicenter Study in Tertiary Eye Hospitals of South India. Cornea. 2021 Nov 01; 40(11):1474-1481.
-
Arrhythmogenesis and COVID-19. Cardiol Rev. 2021 Nov-Dec 01; 29(6):289-291.
-
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother. 2021 10 11; 76(11):3045-3058.
-
Lessons from the field: delivering trachoma mass drug administration safely in a COVID-19 context. Trans R Soc Trop Med Hyg. 2021 10 01; 115(10):1102-1105.
-
Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 Pandemic. JAMA Intern Med. 2021 10 01; 181(10):1399-1402.
-
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights. Microbiol Spectr. 2021 10 31; 9(2):e0019721.
-
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine. JAMA Dermatol. 2021 09 01; 157(9):1128-1130.
-
Ischemic Lesions in the Brain of a Neonate With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2021 09 01; 40(9):e340-e343.